Dana-Farber Cancer Institute Financial Analyst Salaries in Baltimore, MD | Comparably
Dana-Farber Cancer Institute is a center dedicated to carrying out adult and pediatric cancer treatment activities and advanced research. read more
EMPLOYEE
PARTICIPANTS
28
TOTAL
RATINGS
198

Dana-Farber Cancer Institute Financial Analyst Salaries in Baltimore, MD

The average Dana-Farber Cancer Institute Financial Analyst in Baltimore, MD earns $62,004 annually. This total compensation is $25,372 less than the US average for a Financial Analyst.

In Baltimore, MD, The Finance Department at Dana-Farber Cancer Institute earns $5,763 more on average than the Business Development Department.

Last updated a year ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$62,004
Average Compensation
$62,004
avg. base

Financial Analyst Salaries at Dana-Farber Cancer Institute

In Baltimore, MD, Financial Analysts earn $5,861 less than Accountants.

Accounting Manager
$115k*
Senior Accountant
$82k*
Business Analyst
$72k*
Accountant
$68k*
Financial Analyst
$62k
* estimated salary

Compensation at Dana-Farber Cancer Institute by Department

In Baltimore, MD, The Finance Department averages $5,763 more than the Business Development Department, and $386 less than the Legal Department

Legal
$81,317 Avg. total comp.
+$386
Finance
$80,931 Avg. total comp.
Business Development
$75,168 Avg. total comp.
-$6k

Financial Analyst Compensation by Gender (All Companies)

The average female Financial Analyst at companies similar size to Dana-Farber Cancer Institute reported making $89,790, while the average male Financial Analyst at similar sized companies reported making $94,632.

Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Financial Analyst at companies similar size to Dana-Farber Cancer Institute reported making $97,825, while the average African American/Black Financial Analyst at similar sized companies reported making $68,750.

How Financial Analysts at Dana-Farber Cancer Institute Rate Their Compensation

The majority of Financial Analysts at Dana-Farber Cancer Institute believe they're compensated fairly. The vast majority (78%) of Financial Analysts at Dana-Farber Cancer Institute are satisfied with their benefits. See more compensation ratings at Dana-Farber Cancer Institute

×
Rate your company